News
-
CARE reaffirms credit ratings of Wockhardt's bank facilities and NCDs
10:04 IST, Sep 07Short Term Bank Facilities (Non-Fund Based) of Rs307.80cr reaffirmed as CARE A3.
-
Wockhardt, Jemincare partner for novel respiratory antibiotic
13:05 IST, Aug 26Wockhardts subsidiary Wockhardt Bio AG has partnered with Chinas Jiangxi Jemincare Group Company (Jemincare) for supplying Wockhardts n
-
Wockhardt ties with Jemincare for novel respiratory antibiotic Nafithromycin
11:12 IST, Aug 26Wockhardt to receive upfront and milestone payments, in addition to royalties.
-
Volumes spurt at Wockhardt Ltd counter
11:00 IST, Aug 26Wockhardt Ltd registered volume of 7.38 lakh shares by 10:50 IST on BSE, a 12.17 fold spurt over two-week average daily volume of 60648
-
Wockhardt partners with Jemincare for development and commercialization of Nafit
9:24 IST, Aug 26For select markets of China, Hong Kong, Macau and Taiwan
-
Wockhardt partners with RDIF to produce and supply Sputnik vaccines
15:21 IST, Aug 13Wockhardt partners with RDIF to produce and supply Sputnik vaccines
-
RDIF, Wockhardt partner to produce Sputnik V and Sputnik Light vaccines against
14:01 IST, Aug 13In particular, Sputnik V demonstrates 83.1% efficacy against the Delta variant of coronavirus - higher than many other vaccines.
-
Wockhardt spurts after agreement to manufacture, supply Sputnik vaccine
12:10 IST, Aug 13Wockhardt jumped 5.1% to Rs 514.25 after company entered into agreement with Dubai-based Enso Healthcare for manufacture & supply for S
-
Hugely successful vaccination roll out made possible by UK - Indian business par
16:37 IST, Jul 27As part of her visit, the High Commissioner was provided with a tour of the state-of-the-art vaccine fill finish facility which is curr
-
Wockhardt reports consolidated net loss of Rs13cr in Q1FY22
15:23 IST, Jul 23The Company recorded substantial growth in Revenue up by 36% over previous quarter & 32% over previous corresponding quarter.
QuickLinks for Wockhardt Ltd.
